Table 3 Sequence of shRNA used for knockdown.

From: Modeling oxaliplatin resistance in colorectal cancer reveals a SERPINE1-based gene signature (RESIST-M) and therapeutic strategies for pro-metastatic CMS4 subtype

Name

Oligo Sequence (5′– 3′)

Notes

shControl_F

CCGGTCTCGCTTGGGCGAGAGTAAGCTCGAGCTTACTCTCGCCCAAGCGAGATTTTTG

 

shControl_R

AATTCAAAAATCTCGCTTGGGCGAGAGTAAGCTCGAGCTTACTCTCGCCCAAGCGAGA

 

PAI1 sh3

CCGGCAGACAGTTTCAGGCTGACTTCTCGAGAAGTCAGCCTGAAACTGTCTGTTTTTG

TRCN0000052271,

NM_000602.1-1041s1c1

PAI1 sh5_F

CCGGGCTGACTTCACGAGTCTTTCACTCGAGTGAAAGACTCGTGAAGTCAGCTTTTTG

 

PAI1 sh5_R

AATTCAAAAAGCTGACTTCACGAGTCTTTCACTCGAGTGAAAGACTCGTGAAGTCAGC

 
Back to article page